Literature DB >> 10615534

Immunopathogenesis of Behçet's disease.

T Lehner1.   

Abstract

A working hypothesis is postulated for the immunopathogenesis of Behçet's disease (BD). Microbial infection induced stress upregulates HSP65 and MICA gene product which stimulate gamma delta and alpha beta T cell receptor positive cells, to generate effector and suppressor T cells (fig. 1). These activated T cells, antibodies and neutrophils induce cytokines to modulate the immune response. The end result of these complex cellular and cytokine immune interactions in HLA-B51 or genetically related subjects is to induce pathological changes consistent with BD.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10615534

Source DB:  PubMed          Journal:  Ann Med Interne (Paris)        ISSN: 0003-410X


  14 in total

Review 1.  Pathogenesis of Adamantiades-Behçet's disease.

Authors:  Christos C Zouboulis; Tobias May
Journal:  Med Microbiol Immunol       Date:  2003-03-05       Impact factor: 3.402

2.  Molecular mechanisms in Behçet's disease.

Authors:  R Rajendram; N A Rao
Journal:  Br J Ophthalmol       Date:  2003-10       Impact factor: 4.638

3.  Serum-soluble selectin levels in patients with Behçet's disease.

Authors:  Aşkin Ateş; Olcay Aydintuğ Tiryaki; Umit Olmez; Hüseyin Tutkak
Journal:  Clin Rheumatol       Date:  2007-01-06       Impact factor: 2.980

4.  Involvement of innate immunity in the pathogenesis of intestinal Behçet's disease.

Authors:  K Nara; M S Kurokawa; S Chiba; H Yoshikawa; S Tsukikawa; T Matsuda; N Suzuki
Journal:  Clin Exp Immunol       Date:  2008-03-10       Impact factor: 4.330

5.  Involvement of Th1 cells and heat shock protein 60 in the pathogenesis of intestinal Behcet's disease.

Authors:  Y Imamura; M S Kurokawa; H Yoshikawa; K Nara; E Takada; C Masuda; S Tsukikawa; S Ozaki; T Matsuda; N Suzuki
Journal:  Clin Exp Immunol       Date:  2005-02       Impact factor: 4.330

6.  Evaluation of KIR3DL1/KIR3DS1 polymorphism in Behçet's disease.

Authors:  B Erer; M Takeuchi; D Ustek; I Tugal-Tutkun; E Seyahi; Y Özyazgan; J Duymaz-Tozkir; A Gül; D L Kastner; E F Remmers; M J Ombrello
Journal:  Genes Immun       Date:  2016-10-06       Impact factor: 2.676

Review 7.  Behçet syndrome: from pathogenesis to novel therapies.

Authors:  Gianluigi Mazzoccoli; Angela Matarangolo; Rosa Rubino; Michele Inglese; Angelo De Cata
Journal:  Clin Exp Med       Date:  2014-12-02       Impact factor: 3.984

8.  Lack of association of tumor necrosis factor-alpha gene polymorphisms with disease susceptibility and severity in Behçet's disease.

Authors:  Aşkin Ateş; Gülay Kinikli; Nurşen Düzgün; Murat Duman
Journal:  Rheumatol Int       Date:  2005-05-05       Impact factor: 2.631

Review 9.  Mucocutaneous lesions of Behcet's disease.

Authors:  Erkan Alpsoy; Christos Constantin Zouboulis; George Edward Ehrlich
Journal:  Yonsei Med J       Date:  2007-08-31       Impact factor: 2.759

10.  Neutrophil hyperchemotaxis in Behçet's disease: a possible role for monocytes orchestrating bacterial-induced innate immune responses.

Authors:  Fabricio Souza Neves; Solange Carrasco; Cláudia Goldenstein-Schainberg; Célio Roberto Gonçalves; Suzana Beatriz Veríssimo de Mello
Journal:  Clin Rheumatol       Date:  2009-08-25       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.